Medication Description: Trioxazin (Trioxazin)
TRIOKSAZIN (Trioxazin). 4- (3, 4, 5-Trimethoxybenzoyl) -morpholine, or N- (3, 4, 5-trimethoxybenzoyl) -tetrahydro-1, 4-oxazine.
Synonyms: Trimetozin, Sedoxazin, Trimetozinum, Trimetozine.
It has a moderate tranquilizing effect, combined with activation, a certain increase in mood without drowsiness and intellectual retardation. Does not suppress mono-and polysynaptic reflexes, and therefore does not have a muscle relaxant action.
Applied with neurotic disorders, occurring with a predominance of hypostenic manifestations (weakness, lethargy, lethargy).
The drug is prescribed by mouth (after eating), usually 0.3 g (1 tablet) 2 times a day. In case of mild neurotic conditions, the daily dose may be 0.6 to 0.9 g (1 tablet 2 to 3 times a day), and with severe symptoms, increase the dose after 3 to 4 days to 1, 2 to 1, 8 g per day (4 to 6 tablets in total; in some cases, the dose may be increased to 10 tablets per day).
Children prescribed in smaller doses in accordance with the age of 1/4 - 1/2 1 tablet up to 3 - 5 times a day).
Trioxazin is usually well tolerated and can be used in inpatient and outpatient settings. When taking relatively large doses, weakness, lethargy, mild nausea, drowsiness, in some cases allergic reactions, dyspeptic symptoms, dry mouth and throat can be observed. Rarely observed increased anxiety, tension, fear. With prolonged use of trioxazin (as well as other tranquilizers), the development of mental addiction is possible.
Form release: pills to 0.3 g in a package of 20 pieces.
Storage: List B.